Ohio Public Employees Retirement System (OPERS)’s Cytokinetics CYTK Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,769	Closed	-$677K	–	2000
2022 Q4	$677K	Sell	14,769 -3,810	-21%	-$164K	﹤0.01%	1238
2022 Q3	$900K	Hold	18,579	–	–	﹤0.01%	1232
2022 Q2	$730K	Sell	18,579 -19,051	-51%	-$767K	﹤0.01%	1301
2022 Q1	$1.39M	Sell	37,630 -28,999	-44%	-$1.03M	﹤0.01%	1188
2021 Q4	$3.04M	Hold	66,629	–	–	0.01%	972
2021 Q3	$2.38M	Hold	66,629	–	–	0.01%	1059
2021 Q2	$1.32M	Hold	66,629	–	–	﹤0.01%	1216
2021 Q1	$1.55M	Hold	66,629	–	–	0.01%	1133
2020 Q4	$1.39M	Sell	66,629 -14,200	-18%	-$260K	0.01%	1110
2020 Q3	$1.75M	Hold	80,829	–	–	0.01%	915
2020 Q2	$1.91M	Sell	80,829 -13,815	-15%	-$259K	0.01%	929
2020 Q1	$1.12M	Buy	94,644 +10,752	+13%	+$137K	0.01%	1010
2019 Q4	$890K	Buy	83,892 +7,897	+10%	+$81.1K	﹤0.01%	1179
2019 Q3	$865K	Sell	75,995 -23,330	-23%	-$293K	﹤0.01%	1214
2019 Q2	$1.12M	Sell	99,325 -9,550	-9%	-$92.1K	0.01%	1166
2019 Q1	$881K	Buy	108,875 +25,488	+31%	+$187K	﹤0.01%	1246
2018 Q4	$527K	Buy	83,387 +21,268	+34%	+$156K	﹤0.01%	1271
2018 Q3	$612K	Sell	62,119 -11,410	-16%	-$91.6K	﹤0.01%	1347
2018 Q2	$610K	Hold	73,529	–	–	﹤0.01%	1377
2018 Q1	$529K	Sell	73,529 -6,951	-9%	-$59.6K	﹤0.01%	1371
2017 Q4	$656K	Buy	80,480 +54,333	+208%	+$617K	﹤0.01%	1335
2017 Q3	$379K	Sell	26,147 -24,919	-49%	-$340K	﹤0.01%	1429
2017 Q2	$618K	Hold	51,066	–	–	﹤0.01%	1310
2017 Q1	$656K	Hold	51,066	–	–	﹤0.01%	1262
2016 Q4	$539K	Hold	51,066	–	–	﹤0.01%	1304
2016 Q3	$469K	Hold	51,066	–	–	﹤0.01%	1318
2016 Q2	$485K	Buy	51,066 +32,360	+173%	+$266K	﹤0.01%	1259
2016 Q1	$132K	Hold	18,706	–	–	﹤0.01%	1465
2015 Q4	$196K	Buy	18,706 +11,368	+155%	+$111K	﹤0.01%	1384
2015 Q3	$49K	Buy	+7,338	New	+$50.1K	﹤0.01%	1775

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s CYTK Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 14,769 shares — an estimated $677K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CYTK in Q3 2015 and held it in 30 quarters. The position peaked at $3.04M in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 14,769 Cytokinetics shares in Q1 2023, an estimated $677K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Cytokinetics in Q3 2015 and held it in 30 quarters.
Ohio Public Employees Retirement System (OPERS)'s Cytokinetics position peaked at $3.04M in Q4 2021.
262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.